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In the present study, we have analyzed the role of the
molecular chaperone Hsp60 in protection of Saccharo-
myces cerevisiae against oxidative damage. We con-
structed mutant strains in which the levels of Hsp60
protein, compared with wild-type cells, were four times
greater, and the addition of doxycycline gradually re-
duces them to 20% of wild-type. Under oxidative-stress
conditions, the progressive decrease in Hsp60 levels in
these mutants resulted in reduced cell viability and an
increase in both cell peroxide species and protein car-
bonyl content. Protection of Fe/S-containing enzymes
from oxidative inactivation was found to be dose-de-
pendent with respect to Hsp60 levels. As these enzymes
release their iron ions under oxidative-stress condi-
tions, the intracellular labile iron pool, monitored with
calcein, was higher in cells with reduced Hsp60 levels.
Consistently, the iron chelator deferoxamine protected
low Hsp60-expressing cells from both oxidant-induced
death and protein oxidation. These results indicate that
the role of Hsp60 in oxidative-stress defense is explained
by protection of several Fe/S proteins, which prevent
the release of iron ions and thereby avert further
damage.
Heat shock proteins (Hsps)1 are a family of proteins that act
both under normal (where Hsps account for 5–10% of the total
protein) and stress conditions (where they are overexpressed).
Stress situations include heat shock, glucose deprivation, ex-
posure to free radicals, infection by pathogens, and tissue in-
juries (1, 2). A common aspect of these stress-inducing condi-
tions is that they give rise to proteins with non-native
conformations. All known stresses, when sufficiently intense,
induce Hsp expression. Hsps are therefore also referred to as
stress proteins and constitute an important part of the stress
response. Hsps are highly conserved among species and carry
out such essential functions as protein translocation, folding,
and assembly under normal cellular conditions (3, 4). As a
result, they have also been called “molecular chaperones.”
Many members of the HSP60 family are constitutively ex-
pressed and are found in abundance in prokaryotes, chloro-
plast, and mitochondria. Hsp60 is an essential mitochondrial
chaperone and promotes the folding of many proteins imported
into the mitochondrial matrix. It also directs several proteins to
the intermembrane space (5–7). It is generally assumed that
mitochondrial Hsp60 works according to a similar mechanism
to its prokaryotic homologue, GroEL. GroEL is composed of 14
monomers arranged as a double ring, with a 7-mer in each. In
its central cavity, substrate proteins can be transiently seques-
tered from the medium and allowed to mature in solitary con-
finement. The 10-kDa co-chaperonin (Hsp10 or GroES in bac-
teria) exists as a 7-mer ring-shaped oligomer. Newly imported
proteins are released by an ATP-dependent reaction regulated
by the co-chaperone Hsp10 (8–9). In short, unfolded proteins
can be bound inside the central cavity of the large Hsp60. ATP
binding and hydrolysis induces a large conformational shift,
which changes the properties of the binding sites and opens the
cavity. The substrate is eventually released in the folded con-
formation, possibly after several cycles of binding and release
(10). In Saccharomyces cerevisiae, Hsp60 is essential for viabil-
ity at all temperatures (this is consistent with its constitutive
expression), and its concentration in the mitochondrial matrix
is also increased 2- to 3-fold at 42 °C (6). Such induction reflects
an increased requirement for this chaperonin to protect preex-
isting proteins from denaturation and aggregation.
Davidson et al. (11, 12) demonstrated that in yeast, anaero-
bic cells are several orders of magnitude more resistant to heat
shock than aerobic cells. Aerobic heat stress also led to an
increase in mitochondrial membrane damage, which was re-
duced 100-fold under anaerobic conditions. The authors
showed that heat stress generates oxidative stress, supporting
the idea that antioxidant enzymes play a major role in protec-
tion against heat-induced cell death in yeast. Mutants deleted
for the antioxidant genes catalase, superoxide dismutase, and
cytochrome c peroxidase were more sensitive to the lethal effect
of heat shock than isogenic wild-type cells. Overexpression of
catalase and superoxide dismutase genes caused an increase in
thermotolerance (11). A common signal has been proposed for
heat stress and oxidative stress in cell culture, suggesting that
exposure of the hydrophobic domains of proteins represents the
most common early signal in the activation pathway of the heat
shock factor (13).
Yeast can adapt to H2O2 and superoxide-generating drugs by
inducing two distinct but overlapping stimulons (14, 15). The
H2O2 stimulon includes the induction of many Hsps, with
Hsp104 and Hsp12 being those most highly induced (14- and
10-fold, respectively) (16). Some other Hsps have been directly
related with conferring resistance against oxidative stress (1).
These include the cytoplasmic Hsp70, which is highly inducible
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(17), and the newly described chaperone Hsp33 which plays an
important role in the bacterial system toward oxidative stress.
To date, Hsp33 is the only chaperone whose function is regu-
lated by environmental redox conditions, and it is directly
activated by disulfide bonds formation (18). The non-ATP-
dependent Hsps (such as Hsp33) have been referred to as
“holdases,” in contrast to the ATP-dependent “foldases” (such
as Hsp60 and Hsp70) (19). Holdases bind stably to folding
intermediates and suppress lethal aggregation, and they also
interact with foldases, allowing the efficient release of inter-
mediates and their successful refolding to their native state
when conditions return to normal. However, with the exception
of Escherichia coli Hsp33, which has been shown to protect
oxidatively damaged proteins from irreversible aggregation
(18), very little is known about the mechanisms by which Hsps
protect against oxidative stress.
It is interesting to note that in previous work, we identified
mitochondrial Hsp60 in yeast (20) and DnaK (the bacterial
Hsp70) in E. coli (21) as major oxidized proteins under oxida-
tive stress. Although members of different Hsp families, this
parallelism led us to study their physiological relevance both in
E. coli and S. cerevisiae upon oxidative stress. Our group has
also recently published a report on the protective role of DnaK
of alcohol dehydrogenase E from oxidative damage (22). In the
present study, the expression of the HSP60 gene under a tet
promoter allowed us to demonstrate the importance of Hsp60
in protecting yeast cells against oxidative stress. We also pro-
pose a possible mechanism to explain this protection linking
Hsp60, Fe/S cluster enzymes, mitochondrial iron homeostasis,
and oxidative damage.
EXPERIMENTAL PROCEDURES
Chemicals—Hydrogen peroxide (30% solution), doxycycline, batho-
phenanthroline sulfonate, menadione sodium bisulfite, 2,4-dinitrophe-
nylhydrazine, mesylate derivative of deferoxamine (DFO), and dihy-
drorhodamine 123 were purchased from Sigma. Calcein-acetoxymethyl
ester was from Molecular Probes. Acrylamide/bisacrilamide solution
was supplied by Bio-Rad. Polyvinylidene difluoride membranes were
from Millipore. The chemiluminescent detection kit was provided by
Tropix.
Yeast Strains and Plasmids—S. cerevisiae CML128 (MATa, ura3-52,
his4, leu2-3,112, trp1) was used as wild-type strain (23). Overexpression
of Hsp60 protein was obtained after integration of BstEII-linearized
pMM132 plasmid at the chromosomal LEU2 locus of CML128 cells.
pMM132 is an integrative plasmid containing HSP60 under the doxy-
cycline-regulated tetO7 promoter and was derived from pCM190 (24).
The strain carrying the integrated pMM132 plasmid was labeled
MML332 and also contained the wild-type HSP60 allele at its original
chromosomal locus. Addition of the antibiotic repressed expression of
the tet construction without affecting the wild-type gene, resulting in
wild-type levels of Hsp60 expression. A conditional mutant in which
HSP60 expression was exclusively doxycycline-regulated was further
obtained from the MML332 strain by deletion of the wild-type HSP60
allele using the kanMX4 cassette (25). The resulting strain, labeled
MML336, was able to grow on glycerol in the absence of doxycycline
(HSP60 expressed), but growth was finally arrested upon addition of
the antibiotic (HSP60 transcription immediately repressed), confirming
the need for Hsp60.
Growth Conditions—Yeast cells were grown aerobically at 30 °C in
YPD medium (1% yeast extract, 2% peptone, 2% glucose) or in YPG
medium (1% yeast extract, 2% peptone, 3% glycerol). Cells from
CML128, MML332, and MML336 strains, growing exponentially under
either fermenting (YPD) or respiring conditions (YPG), were diluted to
A600  0.002 and A600  0.0009, respectively, in order to obtain cells
with different Hsp60 levels. Doxycycline was added to 0, 2, and 4 g/ml
concentration, and growth was allowed for 12 h in YPD medium and
25 h in YPG medium, until approximately reaching to A600  0.5.
Stress Conditions and Viability—Cells obtained as indicated in the
previous paragraph (about 107 cells per ml) were challenged with hy-
drogen peroxide or menadione. These were directly added to the growth
media under the conditions indicated for each experiment. Untreated
cultures were incubated in parallel over the same periods. When indi-
cated, the iron chelator DFO was added at 10 mM concentration 1 h
prior to the stress. Viability was determined by colony counts on YPD
plates after 3 days of incubation at 30 °C and was expressed as the
percentage of the corresponding control cultures.
Preparation of Cell Extracts—Cell extracts were prepared as de-
scribed (26). Protein concentration was determined by the Bradford
method. For Western blot experiments with anti-DNP, protein carbonyl
groups were derivatized with 2,4-dinitrophenylhydrazine as published
(27) with minor variations. Crude extracts were clarified by treatment
with 50% volume of chloroform, vortexed at maximum speed for 1 min,
and centrifuged at 10,000 g for 10 min. The upper buffer solution was
then recovered. Protein concentration was adjusted to 4 mg/ml, SDS
was added to the samples to a final concentration of 6%, and they were
subsequently heated at 100 °C for 3 min. One volume of 10 mM 2,4-
dinitrophenylhydrazine in 10% trifluoroacetic acid was added to 1 vol-
ume of the sample at 25 °C. The reaction was run for 10 min and was
stopped by the addition of 1 volume of 2 M Tris, 10% glycerol, and 15%
2-mercaptoethanol. Samples were ready for loading on SDS-polyacryl-
amide gel electrophoresis (SDS-PAGE).
Western Blot Analysis—SDS-PAGE was performed according to Lae-
mmli (28). Monoclonal antibody anti-Hsp60 was purchased from Stress-
Gen and used at 1:8,000 dilution. It was applied in conjunction with a
rabbit anti-mouse conjugated with alkaline phosphatase (1:25,000 di-
lution, from Tropix) as a secondary antibody. Polyclonal anti-Aco1 ac-
onitase (1:2,000 dilution, a kind gift of R. Lill, Marburg University) and
anti-succinate dehydrogenase (1:1,000 dilution, from B. Lemire, Uni-
versity of Alberta) antibodies were also employed. Rabbit anti-dehydro-
lipoamide succinyltransferase (E2 subunit of -ketoglutarate dehydro-
genase) antibodies were obtained after injection of a KLH-conjugated
peptide (193KKEAAPKKEVTEPKKC208, from Fundacio Bosch i Gim-
pera, University of Barcelona) and applied at a dilution of 1:2,500. The
anti-2, 4-dinitrophenol antibody (from DAKO) was used at a dilution of
1:4,000. A goat anti-rabbit antibody conjugated with alkaline phospha-
tase (1:25,000 dilution, from Tropix) was used as a secondary antibody.
Measurement of Intracellular Oxidation Levels—The oxidant-sensi-
tive probe dihydrorhodamine 123 (Sigma D1054) was used to measure
intracellular oxidation levels in yeast, as described in Madeo et al. (29).
Dihydrorhodamine 123 is an uncharged, nonfluorescent product that
passively diffuses across most cell membranes where it is oxidized to
rhodamine 123, and locates in the mitochondria. Dihydrorhodamine
was added to the cell culture at 2.5 g/ml from a 2.5 mg/ml stock
solution in ethanol, and cells were incubated for 1 h. Hydrogen peroxide
(8 mM) was added as indicated, and an additional incubation of 1 h was
performed. Cells were washed, resuspended in phosphate-buffered sa-
line (10 mM phosphate buffer, 150 mM NaCl, pH 7.0), and viewed
through a fluorescein optical filter (excitation, 465–495 nm; emission,
505), using a Nikon fluorescence microscope. Images were taken using
a Sony camera system. Fluorescence intensity was measured within
15–30 min, from cells treated as described above, using a Shimadzu RF
5000 spectrofluorimeter (excitation, 490 nm; emission, 530 nm). The
emission values were normalized by number of cells.
Enzyme Activities—Cell extracts were obtained using glass beads,
and enzymatic activities were assayed as described in the respective
references: malate dehydrogenase (30), succinate dehydrogenase (31),
and aconitase (32). Activities were expressed as nmolmin1mg1.
Determination of LIP and Total Iron—The intracellular labile iron
pool (LIP) was measured using calcein, a fluorescent metal-sensitive
probe (33). In cell-free systems, calcein binds to both iron (II) and iron
(III) with stability constants of 1014 and 1024 M1, respectively, which
results in quenching its fluorescence (34). After cellular uptake of
calcein-acetoxymethyl ester, intracellular esterases convert the mole-
cule into a nonpermeable acid-form of calcein. Because calcein is insen-
sitive to calcium and magnesium ions up to 1 mM at physiological pH
and because intracellular concentration of other calcein-binding mole-
cules is very low, it is generally accepted that the observed decrease in
calcein fluorescence is due to iron binding. Calcein-acetoxymethyl ester
loading of S. cerevisiae cells was performed on exponential phase cell
cultures untreated or treated in the presence of 8 mM for 1 h. Cells were
washed twice with phosphate-buffered saline and resuspended in the
same buffer at 107 cells/ml. Cells were loaded with calcein-acetoxy-
methyl ester at a final concentration of 5 M (from a 10 mM stock
solution in dimethyl sulfoxide). After a 2-h incubation at 30 °C, cells
were washed twice to remove unincorporated dye, resuspended in phos-
phate-buffered saline, and viewed through a fluorescein optical filter
(excitation, 465–495 nm; emission, 505 nm) using a Nikon fluorescence
microscope. Images were taken as described previously. Fluorescence
intensity was measured within 30 min, from cells treated as described
above, using a Shimadzu RF 5000 spectrofluorimeter (excitation, 485
nm; emission, 525 nm). The emission value was normalized by the
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number of cells. Total cellular iron was determined under reducing
conditions (35), with bathophenanthroline sulfonate as chelator. In
summary, 2  108 exponentially grown cells were washed twice in
MilliQ water, resuspended in 500 l of 3% nitric acid, and digested for
12 h at 98 °C. After removal of the precipitated material by centrifuga-
tion, 400 l of supernatant was taken up and Fe3 was reduced to Fe2
with ascorbic acid (final concentration, 6 mg/ml). Ammonium acetate
was added to obtain a final pH of 5.4. The difference between 535 nm
and 680 nm absorbance was recorded before and after addition of
bathophenanthroline sulfonate (final concentration, 34 g/ml). Cell
numbers and mean cell volumes were determined using a Coulter Z2
counter (Beckman Coulter, Fullerton, CA). A blank sample containing
all of the components except the cells was treated in parallel to measure
nonspecific absorbance. Molar iron concentration was obtained from a
standard curve prepared with ferrous ammonium sulfate.
RESULTS
Regulation of Hsp60 Levels by Doxycycline—Given the defec-
tive growth phenotype of HSP60 null mutants, we constructed
two conditional strain mutants in which the HSP60 gene under
the tet promoter was doxycycline regulable (see Experimental
Procedures). It is possible to obtain cells with different
amounts of Hsp60 protein from these strains, by adjusting time
and doxycycline concentration. To quantify these levels, crude
extracts were obtained from CML128 (wild-type), MML332,
and MML336 cells grown in YPD or YPG with different doxy-
cycline concentrations. YPD-grown (Fig. 1A) and YPG-grown
(Fig. 1B) cells showed repression of HSP60 gene expression by
the antibiotic; similar results were recorded for both culture
media. Control cells (no added doxycycline) displayed a 3.5- to
4-fold increase in Hsp60 expression in strain MML332 and a
2.5- to 3-fold increase in strain MML336 with respect to
CML128 cells. Addition of 4 g/ml doxycycline to the MML332
strain reduced the amount of Hsp60 to that of the wild-type.
When the same dose was added to the MML336 strain, Hsp60
levels were reduced to 15–20% of those found in the wild-type.
Neither Hsp60 overexpression nor underexpression affected
growth in YPD at the indicated times and antibiotic concentra-
tions: all cells showed similar growth curves (data not shown).
However, Hsp60 overexpression did slightly increase duplica-
tion time for cells grown in YPG. In this medium, cells from
strain MML332 duplicated in 260 min, but in only 240 min
when doxycycline was added at 4 g/ml (data not shown).
Hsp60 underexpression, even at levels of around 20% did not
affect viability in any media. All cells remained viable under
these conditions (data not shown).
It is well known that the absence of Hsp60 causes imported
proteins to fold incorrectly and to aggregate into insoluble
complexes (36). We wanted to determine whether the mito-
chondria were still functioning properly under our conditions.
Western blot detection of two enzymes reported to need Hsp60
for proper folding, -ketoglutarate dehydrogenase (7) and ac-
onitase (37), showed no differences (Fig. 1, C and D). This
indicated that even at below normal levels, no insoluble aggre-
gates were produced and no degradation of these proteins took
place.
Strain MML336 arrested growth after about 18–22 h in YPD
and 29–34 h in YPG, following the addition of 4 g/ml doxycy-
cline. However, even at this point, cells were still able to almost
completely recover growth once doxycycline was removed from
the medium (data not shown).
Viability Increases after Oxidative Stress in Cells Overpro-
ducing Hsp60—The effect of Hsp60 in protection against heat
stress was first described 10 years ago (36), but much less is
known about its effects upon oxidative stress. We used our
doxycycline-regulable strains growing in YPG as a model sys-
tem to investigate how varying the quantity of this chaperonin
may affect viability against menadione (a superoxide-generator
compound) and H2O2. As shown in Table I, greater viability
was obtained from cells with higher levels of Hsp60, and re-
sistance was dose-dependent. Differences were especially clear
following menadione treatment. As a control, adding the anti-
biotic to wild-type strain (CML128) at the maximum concen-
tration used (4 g/ml) did not affect resistance to oxidative
stress (data not shown).
During the stationary phase, a general stress response is
required to reduce steady-state levels of damaged cell compo-
nents that cannot be diluted out through cell division (38). To
investigate whether increasing concentrations of Hsp60 have a
protective effect on the stationary phase, cells from strains
MML332 and MML336 were grown in YPD medium for 10 days
and then treated with 50 mM H2O2 for 2 h. Our results showed
that whereas in strain MML332 5% of the cells remained
viable, in strain MML336 only 0.5% remained viable.
Hsp60 Plays a Protective Role against Protein Oxidative
Damage—Carbonyl formation has been extensively used as a
marker for protein oxidation (20, 21, 39, 40). We used this
methodology to analyze the effect of challenging YPG-grown
cells (from MML332 and MML336 strains treated with differ-
ent concentrations of doxycycline) with 10 mM menadione or 8
mM H2O2 for 1 h. Western-blot anti-DNP revealed an increased
level of protein damage in cells with lower Hsp60 levels (Fig.
2A). When menadione was used it was observed that two major
proteins became targets for oxidative damage. As described in
Cabiscol et al. (20) these were the mitochondrial enzymes
dehydrolipoamide acetyltransferase (E2 subunit of pyruvate
dehydrogenase) and dehydrolipoamide succinyltransferase (E2
subunit of -ketoglutarate dehydrogenase). Hsp60 appeared as
a major oxidized band under H2O2 stress. It is worth noting the
strong oxidation of Hsp60 observed in the western pattern
when its concentration declined (Fig 2A, strain MML336 with
2 g/ml doxycycline treated with H2O2). Similar results were
obtained when cultures were grown in YPD medium (Fig. 2C).
The presence of the antibiotic, added to wild-type cells
FIG. 1. Levels of Hsp60 can be regulated by doxycycline with-
out affecting mitochondrial enzymes. Cells from CML128,
MML332 and MML336 strains grown exponentially in YPD (A) or YPG
medium (B–D) were treated with doxycycline, at time zero, at the
indicated concentrations. After incubation for 12 h in the case of YPD
and 25 h in the case of YPG, Western blot analysis of Hsp60 (A and B),
E2 subunit of -ketoglutarate dehydrogenase complex (C) and aconitase
(Aco1) (D) were performed.
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(CML128 strain), at the maximum concentration used, did not
modify the oxidative pattern of damaged proteins under oxida-
tive stress (data not shown).
Peroxide Levels Increase in Hsp60 Depleted Cells under Ox-
idative Stress—To further investigate the role of Hsp60 under
oxidative stress situations, we tested levels of reactive oxygen
species (ROS) by incubating the cells with dihydrorhodamine
123. This fluorescent probe has been extensively used to inves-
tigate oxidative bursts, as it reacts with H2O2 and other reac-
tive oxygen intermediates (29, 41, 42). This substance accumu-
lates in the cell where it is oxidized to the fluorescent
chromophore rhodamine by ROS. In our model, doxycycline
was added to MML332 and MML336 cell cultures grown in
YPG, as described under “Experimental Procedures.” Dihy-
drorhodamine 123 was added at a 2.5 g/ml final concentra-
tion, and cells were incubated for 1 h. At that point, the cells
were challenged with 8 mM H2O2 for 1 h, washed, and resus-
pended in PBS. Cells were immediately viewed under a fluo-
rescence microscope (Fig. 3A), and fluorescence intensity was
measured as described under “Experimental Procedures” (Fig.
3B). Strain MML336 treated with 4 g/ml of the antibiotic
(Hsp60 levels were 15–20% of the wild-type) showed a very
intense rhodamine fluorescence corresponding to a 7-fold in-
crease with respect to unstressed cells. Cells from MML336
strain without doxycycline showed a faint fluorescence under
the microscope (about 2-fold increase), and those treated with 2
g/ml doxycycline presented an intermediate fluorescence level
(about 5-fold increase). Fluorescence in cells from the MML332
TABLE I
Effect of Hsp60 levels on survival under oxidative stress
Cells grown in YPG were treated with doxycycline at the indicated concentrations for 25 h and challenged with 50 mM menadione (60 min) or
10 mM H2O2 (120 min). DFO (10 mM) was added to the cultures 60 min before menadione or hydrogen peroxide. Cell viability is expressed as the
percentage of the corresponding control cultures with an S.D. less than 15%.
Strain Doxycycline(g/ml)
Survival
Menadione Menadione  DFO H2O2 H2O2  DFO
MML332 0 13 18 42 43
MML332 4 0.2 6 16 35
MML336 0 18 23 47 55
MML336 2 9 20 23 40
MML336 4 0.5 7 10 23
FIG. 2. Hsp60 protects proteins from oxidation upon oxidative stress. Cells from MML332 and MML336 strains were grown to
exponential phase in YPG (A and B) or YPD medium (C) as described in Fig. 1, with the indicated doxycycline concentrations. A, cells were treated
with 10 mM menadione (MD) or 8 mM H2O2 for 1 h. B, when indicated, cells were treated for 2 h with 10 mM DFO prior to menadione stress (10
mM, 1 h). C, cells were treated with 20 mM MD for 30 and 60 min. In all cases, untreated cells were used as a control. Oxidatively damaged proteins
were detected by anti-DNP Western blot. Arrows indicate E2 subunits of both pyruvate dehydrogenase (1) and -ketoglutarate dehydrogenase (2),
which were severely oxidized under MD treatment. Asterisks indicate Hsp60, which is also seen as a carbonylated protein.
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strain without antibiotic was also low with only a 2-fold in-
crease. When this strain was treated with 4 g/ml doxycycline,
fluorescence was similar to that seen in strain MML336 plus 2
g/ml doxycycline, which was consistent with their similar
levels of Hsp60. In summary, from this experiment we can
conclude that upon oxidative stress, Hsp60 deficient cells pre-
sented an increased ROS levels that could account for the
majority of the phenotypes previously described.
Hsp60 Protects Mitochondrial Enzymes from Oxidative Inac-
tivation—To investigate a possible mechanism to explain the
results obtained with the fluorescent probe, the activities of
aconitase and succinate dehydrogenase, two enzymes contain-
ing Fe/S clusters, were tested. These types of proteins are
especially important because these clusters are very sensitive
to oxidation (43–46) and liberate iron ions (47, 48). This free
iron would enhance further ROS production throughout the
Fenton and Haber-Weiss reactions (49).
To test the effect of Hsp60 levels on the oxidative inactiva-
tion of these enzymes, cells from MML332 and MML336
strains, grown in YPG, were treated with doxycycline as de-
scribed under “Experimental Procedures.” Enzyme activities
were measured before and after treatment with 8 mM H2O2 for
1 h (Fig. 4A). It is interesting to note that without additional
stress (control cells), both aconitase and succinate dehydrogen-
ase activities were dose-dependent with respect to Hsp60
levels. Furthermore, after addition of H2O2 to the cultures, the
percentage of enzyme inactivation was greater in cells present-
ing lower amounts of Hsp60 with respect to their untreated
controls. Western blot analysis before and after the addition of
H2O2 showed apparently no effect on aconitase or succinate
dehydrogenase levels (Fig. 4B). Again, no antibiotic effect was
observed when added to wild-type cells (data not shown). Inhi-
bition of Fe/S enzymes could give a clue to the nature of the
phenotype observed upon oxidative challenge.
As a control, malate dehydrogenase, an enzyme with no Fe/S
cluster, which has been described as being resistant to oxida-
tive stress (45, 46), showed no significant differences between
control samples and slightly increased activity after H2O2
treatment (Fig. 4A).
Intracellular LIP Increases When Hsp60 Decreases—Inacti-
vation of Fe/S enzymes such as aconitase and succinate dehy-
drogenase (as described above) could result in the release of
their iron ions. Calcein, a fluorescent metal-sensitive probe,
was used to test this hypothesis. Calcein fluorescence is
quenched when it binds the intracellular LIP.
Using our model, cells from MML332 and MML336 strains
grown in YPG for 25 h with different doxycycline concentra-
tions, were untreated or treated in the presence of 8 mM H2O2
for 1 h. Cells were loaded with calcein-acetoxymethyl ester (see
“Experimental Procedures”) for 2 h, viewed under a fluores-
cence microscope (Fig. 5A) and fluorescence intensity was
measured as described under “Experimental Procedures” (Fig.
5B). From these results it was clear that (i) H2O2 stress in-
creased LIP, as there was a decrease in fluorescence compared
with control conditions; (ii) In each mutant, the decrease in
fluorescence after the stress was dependent on Hsp60 content;
and (iii) even under control conditions (no external stress), a
strong correlation existed between fluorescence and Hsp60 lev-
els. Total iron was measured using bathophenanthroline sul-
fonate as described under “Experimental Procedures” to rule
out the possibility of iron accumulation inside the cell could be
different from one strain to another. Results demonstrated that
there were no significant differences in total cell iron (78  15
M) between strains CML128, MML332, and MML336, regard-
less of the presence or absence of doxycycline.
Deferoxamine Protects Low Hsp60-expressing Cells—In this
system, iron release seems an important factor in oxidative
stress sensitivity. Consequently, a ferric iron chelator capable
of permeating the cell, like DFO (50), should be able to rescue
cells from oxidant-induced death, as it has been observed in
fibroblasts from patients affected of Friedreich’s ataxia (51). As
shown in Table I, protection by DFO was especially relevant in
cells presenting low levels of Hsp60; in Hsp60-overexpressing
cells, the effect was negligible. As a control, treatment with 10
mM DFO for 1 h had no effect on cell viability (data not shown).
The same approach was used to test the effect of the iron
chelator on protein carbonylation (Fig. 2B). Addition of DFO to
cells displaying low Hsp60 levels, prior to menadione stress,
resulted in a clear decrease in protein oxidation when com-
pared with the same stressing conditions in the absence of
DFO. Fig. 2B also showed that, regardless the presence of DFO,
cells with high levels of Hsp60 (MML332 without doxycycline)
presented the same level of protein oxidation.
DISCUSSION
The mitochondrial electron transport chain consumes 90%
of cellular oxygen, and superoxide anions are generated as
minor by-products. Despite the high level of antioxidant sys-
tems found in this organelle (52), mitochondrial damage is
probably the most important after oxidative stress (43, 53). We
previously described that when yeast cells are challenged with
oxidative stress, several mitochondrial proteins become selec-
tively oxidized (20). These include, apart from Hsp60, -keto-
glutarate dehydrogenase and pyruvate dehydrogenase. Aconi-
tase, although much less carbonylated, almost completely loses
its activity. In addition, yeast null mutants of sod1 (encoding
FIG. 3. Under oxidative stress, Hsp60 depletion increases peroxide levels. Cells from MML332 and MML336 were grown in YPG medium
and treated with doxycycline as described in Fig. 1. Dihydrorhodamine 123 was added to the cells and 1 h later, challenged with 8 mM H2O2 for
1h. A, fluorescence intensity visualized in a fluorescence microscope. B, relative fluorescence (represented as induction fold) with respect to control
(unstressed) conditions. Each value represents the mean  S.D. from three separate experiments.
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for Cu-Zn superoxide dismutase) present elevated protein car-
bonyls in mitochondria (54) and are respiration-deficient cells.
Inhibition of respiration reverses their negative effect on long-
term viability, where mitochondria exhibit a burst of ROS
production (55). It is interesting to note that a fraction of SOD1,
classically defined as cytosolic, has recently been reported to
locate at the intermembrane space of mitochondria together
with its copper chaperone (54).
It has been demonstrated that protein folding inside mito-
chondria are promoted through a successive action of the
Hsp70 complex and Hsp60 complex (56). Yeast mitochondria
contain three Hsp70 chaperone systems: (i) Ssc1, the main
mitochondrial Hsp70, an essential protein that mediates the
import of proteins into mitochondria from the cytosol and their
subsequent protein folding, assembly, and degradation (57); (ii)
Ecm10, a closely related protein, with an unclear role (58); and
FIG. 4. Lack of Hsp60 negatively affects the activity of Fe/S enzymes upon oxidative stress. MML332 and MML336 cells growing
exponentially in YPG medium were treated with doxycycline as described in Fig. 1. Cells were challenged with 8 mM H2O2 for 1 h. Unstressed cells
were used as controls. A, enzyme activities (nmolmin1mg1) in cell extracts were determined in control (open bars) and treated (closed bars) cells.
The numbers on top of the closed bars indicate the percentage of remaining activity with respect to their untreated controls (set as 100%). Values
given are means of at least three independent experiments with an S.D. of less than 5%. B, cell extracts were analyzed by Western blot using
anti-aconitase (Aco1) and anti-succinate dehydrogenase (Sdh2) antibodies.
FIG. 5. Hsp60 protects cells from oxidative stress by reducing LIP. MML332 and MML336 cells grown to exponential phase in YPG
medium were treated with doxycycline as described in Fig. 1. Cells were challenged with 8 mM H2O2 for 1 h. Unstressed cells were used as controls.
Calcein-acetoxymethyl ester was added to the cells at 5 g/ml for 2 h. A, fluorescence intensity visualized in a fluorescence microscope. B, relative
fluorescence produced in cells untreated (dotted bars) and treated with H2O2 (shaded bars). Each value represents the mean  S.D. from three
separate experiments.
Hsp60 and Oxidative Stress in Yeast44536
 at U
N
IV
ERSITA
T D
E LLEID
A
 on June 30, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
(iii) Ssq1, reported to be 2,000 times less abundant than Ssc1
and implicated in the synthesis and assembly of Fe/S clusters
(59). Hsp60 interacts, in an ATP-dependent manner, with other
proteins and, in doing so, minimizes the probability of these
other proteins interacting inappropriately with one another. It
has been suggested that the majority of Hsps recognize hydro-
phobic regions exposed on the surface of partially misfolded
proteins and facilitate refolding, thus preventing irreversible
aggregation (36, 60). The importance of Hsp60 lies in both its
abundance and, more importantly, its mitochondrial location.
To date, no report has been published explaining how Hsp60
protects cells from injuries associated to oxidative stress. In
this report we have addressed the question using mutant
strains in which the HSP60 gene was under a tet promoter.
These constructions allowed us to obtain cells containing var-
ious amounts of Hsp60. In this model, cells displaying higher
doses of Hsp60 protein were more resistant to both H2O2 and
superoxide anions, in terms of cell viability. Accordingly, pro-
tein carbonylation tested by Western blot showed that under
oxidative stress, modifying Hsp60 levels affected the degree of
protein damage although the targets were the same, as shown
by the Western blot patterns. Also, an increase in intracellular
ROS levels was observed—after oxidative stress—in cells pre-
senting lower levels of Hsp60.
The role of Hsp60 under oxidative-stress conditions can be
inferred from the observation that overexpression of this chap-
eronin protects two enzymes possessing Fe/S clusters from
oxidative inactivation. Given the broad spectrum of substrates,
we believe that Hsp60 may also protect any susceptible protein
exposing hydrophobic regions. However, Fe/S enzymes are es-
pecially interesting because it is known that they liberate their
iron after oxidation (48), producing additional stress (49). The
presence of iron chelators has been shown to protect several
types of cells from oxidative stress (21, 51, 61, 62). Metal ion
toxicity is highlighted by the fact that null mutants of metal-
lothioneins are very sensitive to oxidative stress (63).
In our model, total iron was not increased in cells underex-
pressing Hsp60. The “free” (i.e. non-protein-bound) iron re-
ferred to as LIP represents a part of the intracellular iron that
is chelatable by commonly used chelators. LIP-associated iron
exists in dynamic equilibrium in the cell with other seques-
tered iron forms and is bound to low affinity ligands that have
yet to be completely identified, although substances such as
ADP, ATP, GTP, and citrate are physiologically relevant (64).
Because tissue homogenization may alter the existing equilib-
rium between free and bound iron, as well as its oxidation state
(62), it was only possible to measure relative changes of LIP in
intact cells after the advent of the use of calcein. In our hands,
this iron-sensitive fluorescent probe showed that the ratio be-
tween ferrous and ferric ion, and/or the level of “free” iron was
indeed altered. The results clearly demonstrated that cells
overexpressing Hsp60 displayed reduced LIP after oxidative
stress. Even more importantly, without additional stress,
Hsp60 levels inversely correlated to LIP. The relevance of iron
release was stated by using an iron chelator capable to perme-
ate the cell. Addition of DFO to cultures prior to stressing
compounds clearly preserved cell viability and decreased pro-
tein carbonyl formation significantly. These effects were ob-
served in cells displaying Hsp60 levels equal to or below those
of the wild-type cells. In cells with higher doses of the chapero-
nin, addition of DFO did not offer any additional advantage.
From these results, it was possible to propose a role for
Hsp60 in protection against both endogenous and exogenous
oxidative stress. Under oxidative stress, iron-dependent en-
zymes such as those presenting Fe/S clusters (i.e. aconitase and
succinate dehydrogenase) and heme groups (i.e. cytochromes)
tend to release their metal ions to the medium. Free iron acts
as a catalyst in several oxygen radical reactions (Fenton and
Haber-Weiss reactions) generating toxic side products, such as
the highly reactive hydroxyl radical (65). Partial unfolding,
resulting from oxidative damage, may trigger the binding of
Hsp60 to these proteins. Given that under an acute oxidative
stress ATP levels drastically decrease (20, 46, 66), the capacity
of Hsp60 to refold unfolded proteins will also be reduced. It has
been suggested that upon stress, GroEL reduces its protein-
folding activity and starts to act as a store for proteins, revert-
ing to its normal function when conditions return to normal
(67). Consistently, Hsp60 may act as a shield and prevent iron
release, further protein damage and aggregation. It can also be
deduced that cells with decreased Hsp60 levels will have a
reduced capacity to protect protein from further oxidation that,
in turn, will enhance a rise in LIP and the generation of ROS,
promoting a deleterious cycle.
The role of molecular chaperones other than Hsp60 preserv-
ing the integrity of Fe/S clusters is also crucial to the cell;
nevertheless, the mechanisms to perform it could follow differ-
ent pathways. Mutations on ssq1 and jac1 genes, which are
involved in synthesis and assembly of these clusters, alters iron
homeostasis, leading to mitochondrial damage and inability to
carry out respiratory metabolism (68, 69). In addition, yeast
mitochondrial Hsp70s, Ssq1 and Ssc1, participate in the mat-
uration of Yfh1 (70), a protein involved in iron homeostasis,
which is the orthologue of the human protein frataxin. Muta-
tions in the frataxin gene are associated with the neurodegen-
erative disease, Friedrich’s ataxia.
It would be interesting to understand the role of free iron in
several human diseases associated with defects in mitochon-
drial Hsp60. Systemic mitochondrial encephalomyopathy with
multiple mitochondrial enzymes deficiencies has been attrib-
uted to the reduced synthesis of Hsp60 (71, 72). In congenital
lactic acidemia, which is characterized by reduced activities of
a number of mitochondrial enzymes, reduced levels of Hsp60
are suggested to be a more common cause of mitocondrial
disease (73). More recently, a mutation in the gene encoding
mitochondrial Hsp60 was reported as the primary cause of
hereditary spastic paraplegia (74). Furthermore, Hsp60 over-
expression (75) or induction (76) in rat neonatal cardiac cells
protected them against simulated ischemia and reoxygenation-
induced cell death. It did this by maintaining mitochondrial
integrity and the capacity for ATP generation, both of which
are crucial factors in determining survival (75). This protective
property may be used in many therapeutic applications such as
interventions associated with cardiovascular and retinal inju-
ries, as well as in organ preservation and transplantation.
However, because the role of Hsp60 in cardiovascular patho-
physiology has already carefully studied (77), the associated
risk needs to be evaluated.
The precise mechanism that explains why yeast Hsp60 and
E. coli DnaK became carbonylated after oxidative stress re-
mains open to discussion. However, several possibilities could
be suggested. (i) Oxidation of these molecular chaperones may
be a consequence of them acting as “shields” for proteins like
aconitase and succinate dehydrogenase. It has been suggested
that oxidized proteins may contain reactive species that may
damage other proteins (78). (ii) A second possibility relates to
their ATPase activity. ATP (and ADP) easily binds to divalent
metal ions (79) such as iron and copper, which can perform
metal-catalyzed oxidation after H2O2 treatment. (iii) The third
possibility arises from an interesting report which, somewhat
unexpectedly, reveals that Hsp60 and -ketoglutarate dehy-
drogenase bind to mitochondrial DNA (80). These associated
proteins would be damaged because iron ions bound to the
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DNA backbone (81, 82) will trigger the formation of hydroxyl
radicals by the Fenton reaction.
Acknowledgment—We thank Malcolm Hayes for editorial assistance.
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